1

Your cart is empty.



Celebrating 23 YEARS of Regulatory Excellence!
Go with the Most-Trusted Regulations & Guidelines Books on the Market.


Now Taking Orders for Our April 1, 2005 Books!        ALSO Check Out our Books with the ICH E6(R3) GUIDELINE FOR GOOD CLINICAL PRACTICE       See our BOOKSTORE Drop-Down Menu for included titles

Book 3C:  2024 The Official Investigator's Handbook for Conducting Cancer Clinical Trials

Book 3C: 2024 The Official Investigator's Handbook for Conducting Cancer Clinical Trials

$ 18.95

Return to Previous Page

This spiral-bound, 5.5" x 7.5" book is a compilation of documents from various US government cancer research divisons developed to assist investigators and their site staff on conducting cancer clinical trials.  It includes such topics as:

• How to write a cancer clinical trial protocol
• Developing an informed consent form
• Reporting adverse events

It also includes the latest Common Terminology Criteria for Adverse Events (CTCAE).


What's the Price?
• 1-249 copies:  $18.95             • 250-499 copies:  $17.95
• 500-749 copies: $16.95          • 750+ copies:  $15.95

Custom Cover Prices*?
• 1-24 copies:  unavailable             • 25-100 copies:  $2.00/book
• 100-249 copies: $1.00/book        • 250+ copies:  No charge


* Based on quantities of a single book title

•  A Handbook for Clinical Investigators Conducting
  
Therapeutic Clinical Trials Supported by CTEP, DCTD, NCI
      2014 (Version 1.2)

•  Letter of Intent Instructions
      NCI/CTEP Career Development

Components of a Competitive Letter of Intent
      Investigational Drug Branch, CTEP, DCTD, National Cancer
      Institute

•  Protocol Authoring and Submission Guidelines Handbook
      NCI/Cancer Therapy Evaluation Program

•  NCI Consent Form Template for Adult Cancer Trials
      Version Date May 12, 2013

•  NCI Guidelines For Investigators: Adverse Event
   Reporting Requirements For DCTD (CTEP and CIP) and
   DCP INDs and IDEs

      Effective September 16, 2013

•  NCI Guidelines For Auditing Clinical Trials for the NCI
   National Clinical Trials Network (NCTN) Program,
   Community Clinical Oncology Program (CCOP)/NCI    Community Oncology Research Program (NCORP) and    Research Bases

      Clinical Trials Monitoring Branch, Division of Cancer Treatment
       and Diagnosis, National Cancer Institute

•  Common Terminology Criteria for Adverse Events
   (CTCAE)

      Version 5.0, Published: November 27, 2017
      U.S.Department of Health and Human Services, National
      Institutes of Health, National Cancer Institute

Click here to see an enlarged pdf cover